GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (WBO:ABBV) » Definitions » Cyclically Adjusted PB Ratio

AbbVie (WBO:ABBV) Cyclically Adjusted PB Ratio : 44.57 (As of Apr. 30, 2024)


View and export this data going back to 2018. Start your Free Trial

What is AbbVie Cyclically Adjusted PB Ratio?

As of today (2024-04-30), AbbVie's current share price is €148.86. AbbVie's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €3.34. AbbVie's Cyclically Adjusted PB Ratio for today is 44.57.

The historical rank and industry rank for AbbVie's Cyclically Adjusted PB Ratio or its related term are showing as below:

WBO:ABBV' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 33.47   Med: 43.7   Max: 57.36
Current: 43.63

During the past years, AbbVie's highest Cyclically Adjusted PB Ratio was 57.36. The lowest was 33.47. And the median was 43.70.

WBO:ABBV's Cyclically Adjusted PB Ratio is ranked worse than
99.23% of 651 companies
in the Drug Manufacturers industry
Industry Median: 1.76 vs WBO:ABBV: 43.63

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

AbbVie's adjusted book value per share data for the three months ended in Dec. 2023 was €5.380. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €3.34 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


AbbVie Cyclically Adjusted PB Ratio Historical Data

The historical data trend for AbbVie's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Cyclically Adjusted PB Ratio Chart

AbbVie Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 44.43 45.74 50.43 41.86

AbbVie Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.06 38.14 40.72 41.86 -

Competitive Comparison of AbbVie's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, AbbVie's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AbbVie's Cyclically Adjusted PB Ratio falls into.



AbbVie Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

AbbVie's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=148.86/3.34
=44.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, AbbVie's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=5.38/129.4194*129.4194
=5.380

Current CPI (Dec. 2023) = 129.4194.

AbbVie Quarterly Data

Book Value per Share CPI Adj_Book
201403 2.136 99.695 2.773
201406 2.413 100.560 3.106
201409 2.262 100.428 2.915
201412 0.888 99.070 1.160
201503 0.799 99.621 1.038
201506 2.963 100.684 3.809
201509 2.651 100.392 3.418
201512 2.250 99.792 2.918
201603 2.578 100.470 3.321
201606 3.082 101.688 3.922
201609 3.547 101.861 4.507
201612 2.760 101.863 3.507
201703 2.937 102.862 3.695
201706 3.356 103.349 4.203
201709 3.515 104.136 4.368
201712 2.705 104.011 3.366
201803 1.816 105.290 2.232
201806 -1.908 106.317 -2.323
201809 -1.664 106.507 -2.022
201812 -5.020 105.998 -6.129
201903 -4.685 107.251 -5.653
201906 -5.128 108.070 -6.141
201909 -5.051 108.329 -6.034
201912 -4.973 108.420 -5.936
202003 -4.544 108.902 -5.400
202006 7.403 108.767 8.809
202009 7.344 109.815 8.655
202012 6.089 109.897 7.171
202103 6.522 111.754 7.553
202106 5.904 114.631 6.666
202109 6.515 115.734 7.285
202112 7.711 117.630 8.484
202203 8.368 121.301 8.928
202206 7.840 125.017 8.116
202209 9.135 125.227 9.441
202212 9.206 125.222 9.515
202303 7.028 127.348 7.142
202306 6.729 128.729 6.765
202309 6.419 129.860 6.397
202312 5.380 129.419 5.380

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AbbVie  (WBO:ABBV) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


AbbVie Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of AbbVie's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AbbVie (WBO:ABBV) Business Description

Industry
Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

AbbVie (WBO:ABBV) Headlines

From GuruFocus

Abbvie Inc at Cowen Health Care Conference Transcript

By GuruFocus Research 01-22-2024

Q2 2023 Abbvie Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2022 Abbvie Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2023 Abbvie Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Abbvie Inc will Acquire ImmunoGen Inc M&A Call Transcript

By GuruFocus Research 01-22-2024